Mylan announced the launch of Dexmethylphenidate Hydrochloride Extended-Release (ER) Capsules, 30mg, the generic version of NovartisFocalin XR.

Dexmethylphenidate HCl is a central nervous system stimulant indicated for the treatment of attention deficit hyperactivity disorder (ADHD)

RELATED: Psychiatric Disorders Resource Center

Dexmethylphenidate, the more pharmacologically active d-enantiomer of racemic methylphenidate, is thought to block the reuptake of norepinephrine and dopamine into the presynaptic neuron and increase the release of these monoamines into the extraneuronal space.

Mylan has been awarded 180 days of marketing exclusivity.

For more information call (800) RX-MYLAN or visit